MissionIR Articles

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) for the three and six months ended…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday announced voting results of its annual general and special meeting of shareholders (“AGM”). According to the update, shareholders voted in…

Canopy Rivers (TSX: RIV) (OTC: CNPOF) on Monday announced that the most recent addition to its portfolio of disruptive cannabis companies, Dynaleo Inc., has received its Standard Processing License from Health Canada. According to the…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced appointment of Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED), (NYSE: CGC) Chief Financial Officer Mike Lee to its Board of…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday released its audited consolidated financial statements for the fiscal year ended March 31, 2020 (“FY 2020”) and management’s discussion and…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced a revised date for the reporting of its financial results for the fourth quarter and fiscal year ended March 31,…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that it will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced a C$2 million investment in Dynaleo Inc., an Edmonton-based company focused on white-label manufacturing of edible cannabis gummies for the…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its 49%-owned joint venture in Leamington, Ontario, PharmHouse Inc., received a license amendment from Health Canada allowing for cultivation…

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the expansion of its strategic advisory board to add Thirty Five Ventures, the business owned by NBA star Kevin Durant…

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its class A subordinated voting shares began trading on the Toronto Stock Exchange (the “TSX”) under the…

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced its receipt of conditional approval from the Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (the “TSXV”) and list its class A…

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company Radicle Medical Marijuana Inc. has received Health Canada approval for its production facility expansion project. According to the update, the approval…